Myneng Tech Secures Tens of Millions in Funding for Brain-Inspired Medical Chips
Myneng Tech, a company specializing in advanced bio-inspired neuromorphic chips, has successfully completed a funding round of tens of millions of yuan, co-led by BlueRun Ventures and Xichuangtou. The raised capital will be allocated to the mass production and iteration of medical-grade standardized modules, the implementation of a closed-loop physiological regulation system, and the integration of its technology into the ecosystem of domestic medical device manufacturers.
Myneng Tech's CEO observed a paradigm shift in the global medical hardware industry, noting that traditional MCU+ANN solutions struggle with the continuous, faint, and noisy physiological signals from the human body. Existing approaches face challenges in power consumption, latency, and safety for applications like long-term wearable monitoring, closed-loop neural interventions, and chronic disease management. To address these issues, Myneng Tech focuses on developing upstream, low-level computing infrastructure for medical devices, creating a native hardware and software platform for physiological sensing, event-based computation, and secure regulation.
The company's proprietary Spiking Neural Network (SNN) core mimics the asynchronous logic of the human brain, designed specifically for temporal physiological signals. This architecture activates computational units only when significant physiological events occur, such as changes in EEG, ECG, or EMG signals, entering a deep sleep state otherwise. This significantly reduces power consumption, enabling 24/7 continuous monitoring and solving the battery life problem for long-term wearable devices. Myneng Tech offers a tiered delivery system, from raw hardware to full solutions including registration support, catering to diverse clients from large manufacturers to startups founded by clinicians. Their commercial strategy involves accelerating adoption in consumer healthcare for quick cash flow and market validation, while simultaneously developing high-value solutions for serious neurological conditions.
Myneng Tech's development of bio-inspired SNN chips for medical devices addresses a critical bottleneck in the healthcare technology sector: the efficient and accurate processing of complex physiological data. By moving beyond traditional computational models, the company aims to overcome limitations in power consumption, latency, and signal fidelity, which are crucial for next-generation medical applications like continuous monitoring and closed-loop interventions. The company's strategy of providing a tiered ecosystem of solutions, from hardware modules to comprehensive registration support, intelligently caters to the varied capabilities of medical device manufacturers, from large enterprises to clinical innovators. This approach could significantly accelerate the adoption of advanced physiological computing, fostering a more integrated and responsive healthcare landscape. The long-term success will hinge on demonstrating robust clinical efficacy, navigating complex regulatory pathways, and scaling production while maintaining the integrity of their proprietary technology against the backdrop of an increasingly competitive AI-driven medical device market.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.